InMode Ltd., a global leader in medical technologies, will be represented by its Chief Medical Officer, Dr. Spero Theodorou, at the 23rd Annual Needham & Company Virtual Healthcare Conference. The conference, taking place from April 8-11, 2024, will bring together industry leaders to discuss groundbreaking developments and future prospects in healthcare. InMode will be participating in the event on April 9th. Dr. Theodorou, along with the CEO Moshe Mizrahy, and CFO Yair Malca, will engage in a fireside chat moderated by Mike Matson, a Senior Equity Research Analyst. The conference will provide an opportunity for attendees to interact with InMode’s leadership team, gaining insights into the company’s business model, product pipeline, and market positioning. InMode’s participation in the conference highlights its commitment to transparency, innovation, and shareholder value, solidifying its position as a frontrunner in the field of medical aesthetics.
Recent Posts
- ALL YOU NEED TO KNOW ABOUT BACK LIPOSUCTION
- How Is Smartlipo Laser Liposuction Different from Other Procedures?
- How Long Does It Take to See Results after Buttock Liposuction?
- Spero to Represent InMode at Needham Virtual Healthcare Conference
- How Does Facial Liposuction in New York Enhance Your Appearance?